Development of Marine-Derived Compounds for Cancer Therapy

Mar Drugs. 2021 Jun 15;19(6):342. doi: 10.3390/md19060342.

Abstract

Cancer has always been a threat to human health with its high morbidity and mortality rates. Traditional therapy, including surgery, chemotherapy and radiotherapy, plays a key role in cancer treatment. However, it is not able to prevent tumor recurrence, drug resistance and treatment side effects, which makes it a very attractive challenge to search for new effective and specific anticancer drugs. Nature is a valuable source of multiple pharmaceuticals, and most of the anticancer drugs are natural products or derived from them. Marine-derived compounds, such as nucleotides, proteins, peptides and amides, have also shed light on cancer therapy, and they are receiving a fast-growing interest due to their bioactive properties. Their mechanisms contain anti-angiogenic, anti-proliferative and anti-metastasis activities; cell cycle arrest; and induction of apoptosis. This review provides an overview on the development of marine-derived compounds with anticancer properties, both their applications and mechanisms, and discovered technologies.

Keywords: cancer therapy; marine-derived compounds; mechanism; technology.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Aquatic Organisms / chemistry*
  • Biological Products / isolation & purification
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Carcinogenesis / drug effects
  • Cell Cycle / drug effects
  • Clinical Trials as Topic
  • Drug Development / methods*
  • Drug Discovery / methods*
  • Humans
  • Neoplasms / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Biological Products